Last week, AMCP Principal Research Scientist Pam Pawloski, PharmD, BCOP, FCCP, presented a project poster at ISPE 2026 in Milan, where she and Cate shared early findings and connected in person with our research collaborators from Italy and Denmark.
AMCP Research Rundown — Helping Patients with NSCLC Access Targeted, Personalized Treatments
What’s AMCP Research Institute (ARI) been working on lately? This week, we’re giving an update on the ARI Project, Advancing Coverage for Comprehensive Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC): A LUNGevity and American Cancer Society Cancer Action Network (ACS CAN) Research Initiative.
This project aims to better understand how health plans make coverage decisions for comprehensive biomarker testing, a critical step in helping patients with NSCLC access targeted, personalized treatments.
The survey has been finalized and is slated to launch next week to regional and mid-size health plans. It will explore factors that influence coverage decisions, including how clinical guidelines are interpreted, concerns about different testing approaches, and how coverage policies are communicated to providers.
Findings from this work will help identify opportunities to improve consistency in coverage decisions and expand patient access to biomarker testing and precision medicine.
Learn more about AMCP's Precision Medicine Initiative.
As always, feel free to reach out to the AMCP Research Institute team with any questions about ARI’s work.
Julia Marsh
Director, Projects & Operations
Published on August 21, 2026
Related
We’re excited to announce that the ARI–Lilly Medication Therapy Management (MTM) MIND project is moving from planning to implementation! Over the past several months, the project team and expert advisors have worked together to develop patient education materials, pharmacist training resources, brain health tools, and implementation workflows designed to help adults ages 40-60 understand and address risk factors associated with dementia.
All 50 states have enacted some sort of pharmacy benefit manager (PBM) legislation, but a handful are setting the pace in terms of new laws targeting ownership restrictions, transparency requirements, and compensation models.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
